By Brian Lantier, CFA
NASDAQ:SVRE
READ THE FULL SVRE RESEARCH REPORT
SaverOne (NASDAQ:SVRE) announced on February 18th, another adjustment of the ADS ratio from 1 ADS to 90 common shares to 1 ADS to 1,200 common shares which is effectively another 1 for 13.33 reverse split.
The combined impact of this ratio adjustment and the October 2024 ratio adjustment (from 1 ADS to 5 ordinary shares to 1 ADS to 90 ordinary shares) is effectively a 1-for-240 reverse split since October 2024. While these adjustments have had the desired effect of boosting the stock’s price above the NASDAQ $1 minimum bid requirement for the moment, it has also diluted existing shareholders to the point where they hold almost no meaningful stake.
As we’ve noted, the company’s reliance on equity issuance to fund operations has led to a staggering jump in the share count in just the past 13 months, growing from 69.6 million shares at 12/31/23 to approximately 675 million at 1/31/25. While the ADS ratio adjustments (from 1 to 5 to 1 to 90 and to now 1 to 1200) and the conversion of some 167k ADSs to close to 200 million ordinary shares has limited the total growth of outstanding ADS, this continuous share issuance is a concern for any investors considering SaverOne.
The company has announced a number of new pilot agreements and small contract wins which we detail below. It will be critical for the company to demonstrate that it can convert these small pilots into much larger commercial deployments over the next 24 months.
The company has announced a host of new relationships in the past two months including:
VALUATION
Valuation calculations for SaverOne have been very challenging as the company has financed its operations through dilutive financing that exceeded our forecasts and broad adoption of the company’s technology has been slow to materialize. The company’s shares remain in a negative feedback loop where the company’s share price falls, so it has to issue more shares, which results in more dilution lowering the price of the stock, which results in more shares being issued.
We are adjusting our 12-month target valuation for the company to roughly $7 million while adjusting our projected effective ADS count to 820,000 at the end of 2025 resulting in a new target valuation for the shares of $8.50/ADS but we recognize that many of the factors that go into our calculation of this target are difficult to forecast at this time. We hope to have a clearer picture of the company’s prospects both domestically and internationally after the company reports full-year 2024 results in late March.
SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR.
DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks SCR provides and Zacks SCR receives quarterly payments totaling a maximum fee of up to $40,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.